Corium Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif. , Aug. 3, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that it has commenced an underwritten public…